Insider · CIK 0001862734
Aaron Kantoff
director
Files at AVTX (Avalo Therapeutics, Inc.), TRML (Tourmaline Bio, Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 28, 2025 | TRML Tourmaline Bio, Inc. | UTender of shares Common Stock | -88,281 | - | - | 0 | Oct 28, 2025 |
| Oct 28, 2025 | TRML Tourmaline Bio, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -10,000 | - | - | 0 | Oct 28, 2025 |
| Oct 28, 2025 | TRML Tourmaline Bio, Inc. | DDisposition to issuer Employee Stock Option (Right to Buy)derivative | -16,800 | - | - | 0 | Oct 28, 2025 |
| Oct 24, 2025 | TRML Tourmaline Bio, Inc. | GGift Common Stock | -5,000 | $0.00 | $0 | 88,281 | Oct 24, 2025 |
| Sep 5, 2025 | TRML Tourmaline Bio, Inc. | MOption exercise Common Stock | +37,890 | $0.13 | $4,926 | 83,281 | Sep 9, 2025 |
| Sep 5, 2025 | TRML Tourmaline Bio, Inc. | MOption exercise Common Stock | +10,000 | $9.46 | $95k | 93,281 | Sep 9, 2025 |
| Sep 5, 2025 | TRML Tourmaline Bio, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -37,890 | $0.00 | $0 | 0 | Sep 9, 2025 |
| Sep 5, 2025 | TRML Tourmaline Bio, Inc. | MOption exercise Stock Option (Right to Buy)derivative | -10,000 | $0.00 | $0 | 0 | Sep 9, 2025 |
| Jun 17, 2025 | AVTX Avalo Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +20,100 | $0.00 | $0 | 20,100 | Jun 18, 2025 |
| Jun 4, 2025 | TRML Tourmaline Bio, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +16,800 | $0.00 | $0 | 16,800 | Jun 6, 2025 |
| Mar 28, 2025 | AVTX Avalo Therapeutics, Inc. | MOption exercise Common Stock | +3,167 | - | - | 3,167 | Apr 1, 2025 |
| Mar 28, 2025 | AVTX Avalo Therapeutics, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,167 | $0.00 | $0 | 6,333 | Apr 1, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.